Literature DB >> 8705640

Isotype-specific antibody responses to acute Mycoplasma pneumoniae infection.

J S Seggev1, G V Sedmak, V P Kurup.   

Abstract

BACKGROUND: Mycoplasma pneumoniae-induced respiratory infections affect millions of patients and have been implicated in exacerbation of bronchial asthma. IgE may be involved in such exacerbations. While specific IgG and IgM responses to Mycoplasma pneumoniae are well described, the response of other isotypes is less known.
PURPOSE: To determine whether specific IgE and what subclasses of IgG are formed in response to Mycoplasma pneumoniae infection.
METHODS: We studied 20 patients with acute Mycoplasma pneumoniae infection, in whom the diagnosis was confirmed by a 16-fold increase in complement fixation titer between acute and convalescent serum samples. We developed an enzyme-linked immunosorbent assay (ELISA) for the determination of IgG, IgA, and IgM antibodies specific for Mycoplasma pneumoniae protein antigens. We used Western blotting to confirm the results of the ELISA and to detect Mycoplasma-specific IgG subclasses and IgE.
RESULTS: Changes in Mycoplasma pneumoniae-specific IgG, IgA, and IgM were significant. Western blots of Mycoplasma pneumoniae antigens in 13 convalescent sera showed specific IgG in all, IgM in 11, IgA in 6, and IgE in 10. The IgG response consisted mainly of IgG1 and IgG3, and to a lesser degree of IgG2 and IgG4.
CONCLUSIONS: We conclude that Mycoplasma pneumoniae infection is associated with a significant specific IgA and IgE response, in addition to the well-known responses of IgG and IgM. As IgE is involved in allergic reactions, the production of Mycoplasma pneumoniae-specific IgE may have a role in exacerbation of bronchial asthma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8705640     DOI: 10.1016/S1081-1206(10)63482-5

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  7 in total

1.  Humoral and cellular immunity in children with Mycoplasma pneumoniae infection: a 1-year prospective study.

Authors:  Iwona Stelmach; Malgorzata Podsiadłowicz-Borzecka; Tomasz Grzelewski; Pawel Majak; Wlodzimierz Stelmach; Joanna Jerzyńska; Marta Popławska; Jaroslaw Dziadek
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

2.  Vaccination of BALB/c mice with an avirulent Mycoplasma pneumoniae P30 mutant results in disease exacerbation upon challenge with a virulent strain.

Authors:  S M Szczepanek; S Majumder; E S Sheppard; X Liao; D Rood; E R Tulman; S Wyand; D C Krause; L K Silbart; S J Geary
Journal:  Infect Immun       Date:  2012-01-17       Impact factor: 3.441

3.  The prevalence and identity of Chlamydia-specific IgE in children with asthma and other chronic respiratory symptoms.

Authors:  Katir K Patel; Erica Anderson; Paul S Salva; Wilmore C Webley
Journal:  Respir Res       Date:  2012-04-18

Review 4.  Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications.

Authors:  Takeshi Saraya; Daisuke Kurai; Kazuhide Nakagaki; Yoshiko Sasaki; Shoichi Niwa; Hiroyuki Tsukagoshi; Hiroki Nunokawa; Kosuke Ohkuma; Naoki Tsujimoto; Susumu Hirao; Hiroo Wada; Haruyuki Ishii; Koh Nakata; Hirokazu Kimura; Kunihisa Kozawa; Hajime Takizawa; Hajime Goto
Journal:  Front Microbiol       Date:  2014-08-11       Impact factor: 5.640

Review 5.  Allergic Diseases: A Comprehensive Review on Risk Factors, Immunological Mechanisms, Link with COVID-19, Potential Treatments, and Role of Allergen Bioinformatics.

Authors:  Fahad M Aldakheel
Journal:  Int J Environ Res Public Health       Date:  2021-11-18       Impact factor: 3.390

6.  Immune response to Mycoplasma pneumoniae P1 and P116 in patients with atypical pneumonia analyzed by ELISA.

Authors:  Mette Drasbek; Pernille K Nielsen; Kenneth Persson; Svend Birkelund; Gunna Christiansen
Journal:  BMC Microbiol       Date:  2004-02-05       Impact factor: 3.605

7.  Mast Cells in Lung Homeostasis: Beyond Type I Hypersensitivity.

Authors:  Marcia Campillo-Navarro; Alma D Chávez-Blanco; Isabel Wong-Baeza; Jeanet Serafín-López; Raúl Flores-Mejía; Sergio Estrada-Parra; Iris Estrada-García; Rommel Chacón-Salinas
Journal:  Curr Respir Med Rev       Date:  2014-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.